Suppr超能文献

差异蛋白质组学分析以研究白藜芦醇对心脏的药理预处理机制。

Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol.

作者信息

Bezstarosti Karel, Das Samarjit, Lamers Jos M J, Das Dipak K

机构信息

Cardiovascular Research Center, University of Connecticut School of Medicine, Farmington, CT 06030-1110, USA.

出版信息

J Cell Mol Med. 2006 Oct-Dec;10(4):896-907. doi: 10.1111/j.1582-4934.2006.tb00533.x.

Abstract

Recent studies demonstrated that resveratrol, a grape-derived polyphenolic phytoalexin, provides pharmacological preconditioning of the heart through a NO-dependent mechanism. To further explore the molecular mechanisms involved in resveratrol-mediated cardioprotection, we monitored the effects of resveratrol treatment after ischemia-reperfusion on the protein profile by implementation of proteomic analysis. Two groups of rats were studied; one group of animals was fed resveratrol for 7 days, while the other group was given vehicle only. The rats were sacrificed for the isolated working heart preparation and for isolation of cytoplasmic fraction from left ventricle homogenates to carry out the proteomic as well as immunoblot at baseline and at the end of 30 min ischemia/2-h perfusion. The results demonstrate significant cardioprotection with resveratrol evidenced by improved ventricular recovery and reduced infarct size and cardiomyocyte apoptosis. The left ventricular cytoplasmic fractions were separated by two-dimensional electrophoresis (2-DE). Differentially regulated proteins were detected with quantitative computer analysis of the Coomassie blue stained 2-DE images and identified by MALDI-TOF (MS) and nanoLC-ESI-Q-TOF mass spectrometry (MS/MS). Five redox-regulated and preconditioning- related proteins were identified that were all upregulated by resveratrol: MAPKK, two different alphaB-crystallin species, HSP 27 and PE binding protein. Another HSP27 species and aldose reductase were downregulated and peroxiredoxin- 2 remained constant. The results of the immunoblot analysis of phosphorylated MAPKK, -HSP27 and -alphaB-crystallin and PE binding protein were consistent with the proteomic findings, but not with peroxiredoxin-2. The proteomic analysis showed also downregulation of some proteins in the mitochondrial respiratory chain and matrix and the myofilament regulating protein MLC kinase-2. The results of the present study demonstrate that proteomic profiling enables the identification of resveratrol induced preconditioning-associated proteins which reflects not only changes in their expression level but also isoforms, post-translational modifications and regulating binding or activating partner proteins.

摘要

近期研究表明,白藜芦醇这种源自葡萄的多酚类植物抗毒素,通过一种依赖一氧化氮的机制对心脏起到药理学预处理作用。为了进一步探究白藜芦醇介导的心脏保护作用所涉及的分子机制,我们通过蛋白质组学分析监测了缺血再灌注后白藜芦醇处理对蛋白质谱的影响。研究了两组大鼠;一组动物喂食白藜芦醇7天,而另一组只给予赋形剂。处死大鼠以制备离体工作心脏,并从左心室匀浆中分离细胞质部分,以便在基线以及30分钟缺血/2小时灌注结束时进行蛋白质组学和免疫印迹分析。结果表明白藜芦醇具有显著的心脏保护作用,表现为心室恢复改善、梗死面积减小以及心肌细胞凋亡减少。左心室细胞质部分通过二维电泳(2-DE)进行分离。通过对考马斯亮蓝染色的2-DE图像进行定量计算机分析检测差异调节的蛋白质,并通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)(MS)和纳升液相色谱-电喷雾串联四级杆飞行时间质谱(nanoLC-ESI-Q-TOF)(MS/MS)进行鉴定。鉴定出了5种氧化还原调节和预处理相关蛋白,它们均被白藜芦醇上调:丝裂原活化蛋白激酶激酶(MAPKK)、两种不同的αB-晶状体蛋白、热休克蛋白27(HSP 27)和PE结合蛋白。另一种HSP27和醛糖还原酶被下调,而过氧化物酶体增殖物激活受体γ辅激活因子-2(peroxiredoxin-2)保持不变。磷酸化MAPKK、-HSP27、-αB-晶状体蛋白和PE结合蛋白的免疫印迹分析结果与蛋白质组学结果一致,但与过氧化物酶体增殖物激活受体γ辅激活因子-2不一致。蛋白质组学分析还显示线粒体呼吸链和基质中的一些蛋白质以及肌丝调节蛋白肌球蛋白轻链激酶-2(MLC kinase-2)下调。本研究结果表明,蛋白质组学分析能够鉴定白藜芦醇诱导的预处理相关蛋白,这不仅反映了它们表达水平的变化,还反映了同工型、翻译后修饰以及调节结合或激活伴侣蛋白的变化。

相似文献

1
Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol.
J Cell Mol Med. 2006 Oct-Dec;10(4):896-907. doi: 10.1111/j.1582-4934.2006.tb00533.x.
2
Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart.
J Cell Mol Med. 2008 Sep-Oct;12(5A):1677-89. doi: 10.1111/j.1582-4934.2008.00227.x. Epub 2008 Jan 11.
4
Delayed preconditioning by sevoflurane elicits changes in the mitochondrial proteome in ischemia-reperfused rat hearts.
Anesth Analg. 2011 Aug;113(2):224-32. doi: 10.1213/ANE.0b013e3182239b71. Epub 2011 Jun 9.
7
Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation.
Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H328-35. doi: 10.1152/ajpheart.00453.2004. Epub 2004 Sep 2.
8
Myocardial preconditioning and remote renal preconditioning--identifying a protective factor using proteomic methods?
Basic Res Cardiol. 2006 Mar;101(2):149-58. doi: 10.1007/s00395-005-0565-0. Epub 2005 Nov 11.
10
Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion.
Exp Physiol. 2005 Jul;90(4):593-606. doi: 10.1113/expphysiol.2005.030296. Epub 2005 Apr 15.

引用本文的文献

1
Adrenergic signaling and oxidative stress: a role for sirtuins?
Front Physiol. 2013 Nov 8;4:324. doi: 10.3389/fphys.2013.00324. eCollection 2013.
3
Proteostasis and REDOX state in the heart.
Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H24-37. doi: 10.1152/ajpheart.00903.2011. Epub 2011 Oct 14.
4
Co-ordinated autophagy with resveratrol and γ-tocotrienol confers synergetic cardioprotection.
J Cell Mol Med. 2010 Oct;14(10):2506-18. doi: 10.1111/j.1582-4934.2009.00921.x.
5
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H333-41. doi: 10.1152/ajpheart.01012.2008. Epub 2008 Dec 5.
6
Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart.
J Cell Mol Med. 2008 Sep-Oct;12(5A):1677-89. doi: 10.1111/j.1582-4934.2008.00227.x. Epub 2008 Jan 11.
7
Proteomic analysis of the serum in patients with idiopathic pulmonary arterial hypertension.
J Zhejiang Univ Sci B. 2007 Apr;8(4):221-7. doi: 10.1631/jzus.2007.B0221.

本文引用的文献

2
Resveratrol in cardioprotection: a therapeutic promise of alternative medicine.
Mol Interv. 2006 Feb;6(1):36-47. doi: 10.1124/mi.6.1.7.
3
Proteomics of the heart: unraveling disease.
Circ Res. 2006 Feb 17;98(3):309-21. doi: 10.1161/01.RES.0000201280.20709.26.
4
Application of proteomics in cardiovascular medicine.
Int J Cardiol. 2006 Mar 22;108(1):12-9. doi: 10.1016/j.ijcard.2006.01.002. Epub 2006 Feb 8.
5
Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure.
Cell Biochem Biophys. 2006;44(1):11-29. doi: 10.1385/CBB:44:1:011.
6
Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling.
Toxicol Sci. 2006 Mar;90(1):120-32. doi: 10.1093/toxsci/kfj055. Epub 2005 Dec 1.
10
Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation.
Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H328-35. doi: 10.1152/ajpheart.00453.2004. Epub 2004 Sep 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验